Post hoc analysis of a placebo-controlled trial in 12,031 genotyped adults over 70: aspirin did not reduce ischaemic stroke overall, but in the highest polygenic score quintile it did (HR 0.49) without significantly more major bleeding (HR 1.15).
Secondary analysisn = 12,031
Yu et al. Polygenic Risk Identifies Older Adults Who May Benefit From Aspirin for the Primary Prevention of Ischemic Stroke